Saxenda is approved for weight loss and is commonly prescribed for adults with obesity or overweight conditions tied to other health concerns
Can you explain the methodology for your research
While these strategies remain experimental, they offer hope for patients with recurrent or refractory disease (Plotkin & Blakeley, 2022)
Because of the GI effects, caution is advised in patients with severe gastroparesis (e.g., long-standing diabetic gastroparesis) GLP-1 RAs can worsen gastric emptying delays and are generally not recommended in that scenario
Detectability is a crucial consideration in biomarker discovery, as proteins with excessive missing values or those undetectable in one group are typically excluded during data cleaning and differential analysis, potentially leading to missed findings
Information on 81 cases with a history of psychotic drug use